The largest database of trusted experimental protocols

9 protocols using anti cd28 pe

1

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fluorochrome labeled monoclonal antibodies (mAbs) anti-CD2-FITC, anti-CD3-Alexa 700, anti-CD3-PerCP, anti-CD4-V450, anti-CD4-PE, anti-CD8-APC Fluor 780, anti-CD8-PacBlue, anti-CD16-FITC, anti-CD20 PECy7, anti-CD19-V450, anti-CD20-APCCy7, anti-CD25-PEcy7, anti- CD28-PE, anti-CD28-FITC, anti-CD38-PE, anti-CD39-FITC, anti-CD45-PerCP, anti-CD56-APC, anti-CD57-FITC, anti-CD197-PECy7, anti-HLA-DR, anti-IgM, anti-IgD, anti-Ki67-FITC, anti-Bcl-2-PE, anti-TNF-α-PE, anti-TNF-α-APC, IFN-γ-PcpCy5.5, and IL-2-PECy7 were purchased from BD Biosciences (Franklin Lakes, NJ). Anti-CD45RA-QDOT655 and anti-CD69-FITC mAb were obtained from Invitrogen (Carlsbad, CA). Anti-CD8-Alexa780, anti-CD27-Alexa Fluor 700, and anti-CD38-eFluor 650NC were obtained from E-bioscience (San Diego, CA). Anti-CD24-PEcy7 and anti-CD279-PE (PD-1) were purchased from Biolegend (San Diego, CA).
Human EBV protein and CMV peptide pool of pp65 sequence consisting of 138 peptides (15 mers with 11 amino acid overlaps) was purchased from JPT Peptide Technologies (Berlin, Germany).
All patients were DSA-free with a calculated panel reactive antibody (PRA) ≤20% at enrollment. Patient samples were assessed for donor-specific alloantibody post-transplantation as described previously (18 (link)).
+ Open protocol
+ Expand
2

Evaluating In Vitro Binding Capacity of Immune Checkpoint Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable cell lines were generated to evaluate in vitro binding capacity of anti-PD-1, CD80-Fc, and 4-1BBL-Fc proteins. For this purpose, total RNA was extracted from anti-CD3/CD28 activated human PBMCs, and the first-strand cDNA was synthesized by Thermo cDNA synthesis kit (Thermo Scientific, USA). Human PD-1 (hPD-1), CTLA-4 (hCTLA-4), CD28 (hCD28), and 4-1BB (h4-1BB) coding genes were amplified by PCR using specific primers and separately inserted into pCHO1.0 expression vector. As described earlier, these constructs were transfected to CHO-K1 by electroporation, and then stable cell lines were produced by puromycin/MTX strategy. The expression of these proteins on the surface of transfected CHO-K1 cells was screened by flow cytometry using anti-PD-1-PE (BioLegend™, USA), anti-CD28-PE (BD Pharmingen™, USA), anti-CTLA4-PE (BioLegend), and anti-4-1BB-PE (BioLegend™, USA) antibodies.
+ Open protocol
+ Expand
3

Multi-Marker Phenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD4 PerCP, Anti-CD4 PerCP-cy5.5, anti-CD3 APC, anti-CXCR5-Alexafluor 488, anti-CD45RO PE, anti-CCR7 PE, anti-CD28 PE, anti-CD69 PE, anti-HLA-DR PE, anti-IL-21 PE, anti-IL-4 PE, anti-IFN-γ APC and isotype-matched control mAbs were purchased from BD PharMingen (San Diego, CA, USA). Anti-IL-17 APC and ELISA for determining IL-21 was purchased from eBioscience (San Diego, CA, USA). Anti-IL-22 PE was purchased from R & D Systems (Abingdon, UK). PMA, ionomycin (INO), saponin and Brefeldin A were purchased from Sigma-Aldrich (Fluka, Sigma, USA).
+ Open protocol
+ Expand
4

Cytokine Production in Activated T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were cultured for 6h in complete media (RPMI, HEPES, L-Glutamine, Penicillin, Streptomycin) containing 5% human serum and stimulated with plate-bound α-CD3 monoclonal antibody (plate coated with 2.5 μg/ml, clone OKT-3) and incubated at 37°C, 5% CO2. In order to prevent produced cytokines from being secreted, 10 μg/ml Brefeldin A (Sigma-Aldrich, Steinheim, Germany) was added to the cultures 4h prior to harvesting. Extracellular and intracellular cytokine staining was performed using Cytofix/Cytoperm Kit (BD) according to the manufacturer’s instructions. Antibodies: Anti-CD28 PE or anti-CD28 APC, anti-CD14 APC Cy7, anti-CD4 PeCy7 or anti-CD4 PerCP, anti-IFN-γ FITC (all BD), anti-CD3 PB (BD or Biolegend), anti-TNF PerCP Cy5.5 (Biolegend), anti-IL17 Alexa 647 (Biolegend) or anti-IL17A PE (eBioscience). LIVE/DEAD Aqua Dead Cell Stain (Invitrogen) was used to exclude dead cells. The PBMCs were run on a Beckman Coulter CyAn. Analyses were performed with FlowJo software, version 8.1.0 or higher (Treestar Inc.).
+ Open protocol
+ Expand
5

Multicolor Flow Cytometry Panels

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following flow cytometry antibodies were purchased from BD Biosciences (San Jose, CA): anti-CD3-PE Cy7, anti-CD4-Alexa488, anti-CD8-PacBlu, anti-CD28-PE, anti-CD57-APC, anti-CD45RO-Alexa 700, anti-HLA-DR-APC, anti-CD14-PacBlu, anti-CD11a-FITC, anti-CD16-PE-Cy7, anti-CD163-PE, anti-CD62L-APC, and anti-CD86-Alexa 700. Two multi-color panels were used for T cells, and two panels were used for monocytes. Data were collected using a BD LSRII flow cytometer and analyzed with FCS Express software (DeNovo Software, Los Angeles, CA).
+ Open protocol
+ Expand
6

Comprehensive Immune Profiling of Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
One hundred μL of whole blood was incubated for 30 min at room temperature with optimized doses and combinations of the following anti-human antibodies: anti-CD3-PerCP (SK7, BD, San Jose, CA) or anti-CD3-Alexa Fluor 700 (UCHT1, Thermo Fisher, Waltham, MA, USA), anti-CD8-PE (RPA-T8; BD) or anti-CD8-Alexa Fluor 700 (OKT8; Thermo Fisher), anti-CD4-APC-eFluor 780 (RPA-T4, Thermo Fisher), anti-HLA-DR-FITC or APC-eFluor 780 (LN3, Thermo Fisher), anti-CD38-PE Cy7 or PE-eFluor 610 (HIT2, Thermo Fisher), anti-PD-1-PerCP-eFluor 710 (F38-2E2, Thermo Fisher), anti-CCR7-PE (3D12, Thermo Fisher), anti-CD45RO-PE (UCHL1, BD), anti-CD45RA-PE Cy7 (HI100, BD), anti-CD28-PE (L293, BD), anti-CD57-FITC (TB01, Thermo Fisher), anti-CD95-FITC (DX2, BD) and anti-CD152-PE (BNI3, BD Pharmingen). Next, red blood cells were removed with 1X FACS Lysing Solution (BD) during 20 min at room temperature, followed by a washing step with 1 mL of 1X PBS and fixation in 1% paraformaldehyde. The cells were acquired on a LSR Fortessa cytometer (BD), using the FACS Diva software v. 6.0, within one hour of completing the staining; at least 50,000 CD3+ events were acquired. Data were analyzed with the FlowJo Software version 10.4 (Tree Star, Inc, Ashland, OR, USA). Fluorescence minus one control was included to define positive thresholds.
+ Open protocol
+ Expand
7

PBMC Cryopreservation and Cell Sorting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved PBMCs were thawed, washed, counted, and stained for sorting as previously described (39 (link)). Before staining, an aliquot of 1 million PBMCs was removed, pelleted, and frozen at −80 °C to assess PBMC TL. Thawed cells were first stained with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Invitrogen) for exclusion of non-viable cells, and were then stained with the following fluorescently conjugated monoclonal antibodies: anti-CD4-PE-Texas Red® (Invitrogen); anti-CD3-V450, anti-CD19 PE-CyTM5, anti-CD28-PE, anti-CD45 FITC and anti-CD8-APC (all from BD Biosciences). Stained cells were sorted on a customized BD FACSAriaTM II into the following fractions, using standard gating strategies: CD4+ T-cells (CD45+CD3+CD4+), CD8+ T-cells (CD45+CD3+CD8+), and CD19+ B-cells (CD45+CD3-CD19+). Cells were collected into AIM V serum-free media (Invitrogen), pelleted by centrifugation, and stored at −80 °C.
+ Open protocol
+ Expand
8

T Cell Subset Isolation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were isolated by flow cytometry on a MoFlo (Beckman Coulter) by sorting for CD3+CD4+ and either CD28+ or CD28. The purity of isolated subsets was on average 98%.
All surface staining was carried out in PBS supplemented with 1% human sera and 0.05 % sodium azide using anti-CD3 PC5 (Beckman Coulter) or anti-CD3 FITC, anti-CD4 FITC or anti-CD4 PC5 or anti-CD4 APCCY7, CD45RO PC5 and anti-CD28 PE (all BD) antibody conjugates.
+ Open protocol
+ Expand
9

Phenotypic Analysis of Activated T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
OKT-CIK and R-CIK cells were measured on the 10th and 16th days after RetroNectin and OKT3 stimulating. The cells were harvested and washed in cold PBS and resuspended at 1 × 106 in 100 μL cold PBS consisting of 5% serum. The cells were stained for anti-CD3-APC, anti-CD4-PerCP, anti-CD8-PerCP, anti-CD27-FITC, anti-CD28-PE, anti-CD56-PE, and anti-PD-1-PE purchased from BD Biosciences (San Jose, CA, USA) for 20 minutes on ice. FACS analysis was performed by using a FACSCalibur and CellQuest software (BD Biosciences, San Jose, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!